Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply
- PMID: 19563799
- DOI: 10.1016/j.yexcr.2009.06.024
Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply
Abstract
The glycolytic key regulator pyruvate kinase M2 (M2-PK or PKM2) can switch between a highly active tetrameric and an inactive dimeric form. The transition between the two conformations regulates the glycolytic flux in tumor cells. We developed specific M2-PK-binding peptide aptamers which inhibit M2-PK, but not the 96% homologous M1-PK isoenzyme. In this study we demonstrate that, at normal blood glucose concentrations, peptide aptamer-mediated inhibition of M2-PK induces a significant decrease of the population doubling (PDL rate) and cell proliferation rate as well as an increase in cell size, whereas under glucose restriction an increase in PDL and cell proliferation rates but a decrease in cell size was observed. Moreover, M2-PK inhibition rescues cells from glucose starvation-induced apoptotic cell death by increasing the metabolic activity. These findings suggest that M2-PK is a metabolic sensor which regulates cell proliferation, cell growth and apoptotic cell death in a glucose supply-dependent manner.
Similar articles
-
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.Int J Biochem Cell Biol. 2011 Jul;43(7):969-80. doi: 10.1016/j.biocel.2010.02.005. Epub 2010 Feb 13. Int J Biochem Cell Biol. 2011. PMID: 20156581 Review.
-
Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.Int J Cancer. 2008 Jul 15;123(2):312-321. doi: 10.1002/ijc.23512. Int J Cancer. 2008. PMID: 18425820
-
The tumor metabolome.Anticancer Res. 2003 Mar-Apr;23(2A):1149-54. Anticancer Res. 2003. PMID: 12820363
-
Pyruvate kinase type M2: a crossroad in the tumor metabolome.Br J Nutr. 2002 Jan;87 Suppl 1:S23-9. Br J Nutr. 2002. PMID: 11895152 Review.
-
Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.Anticancer Res. 2007 Nov-Dec;27(6B):3963-71. Anticancer Res. 2007. PMID: 18225557
Cited by
-
Anticancer agent shikonin is an incompetent inducer of cancer drug resistance.PLoS One. 2013;8(1):e52706. doi: 10.1371/journal.pone.0052706. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23300986 Free PMC article.
-
Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.PLoS One. 2012;7(8):e43250. doi: 10.1371/journal.pone.0043250. Epub 2012 Aug 17. PLoS One. 2012. PMID: 22912838 Free PMC article.
-
Connecting the dots between PubMed abstracts.PLoS One. 2012;7(1):e29509. doi: 10.1371/journal.pone.0029509. Epub 2012 Jan 3. PLoS One. 2012. PMID: 22235301 Free PMC article.
-
Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture.Cytotechnology. 2021 Apr;73(2):217-232. doi: 10.1007/s10616-021-00459-2. Epub 2021 Feb 20. Cytotechnology. 2021. PMID: 33927477 Free PMC article.
-
Human pyruvate kinase M2: a multifunctional protein.Protein Sci. 2010 Nov;19(11):2031-44. doi: 10.1002/pro.505. Protein Sci. 2010. PMID: 20857498 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous